A carregar...

Safety concerns about intravenous iron therapy in patients with chronic kidney disease

Anaemia in chronic kidney disease (CKD) is managed primarily with erythropoiesis-stimulating agents (ESAs) and iron therapy. Following concerns around ESA therapy, intravenous (IV) iron is being administered more and more worldwide. However, it is still unclear whether this approach is safe at very...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Kidney J
Main Authors: Del Vecchio, Lucia, Longhi, Selena, Locatelli, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792617/
https://ncbi.nlm.nih.gov/pubmed/26985378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfv142
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!